PPT-Regional WHO Measles and Rubella Focal Point Meeting

South East Asia Region 1 21 June 2016 Geneva Switzerland Regional Measles and Rubella Goals 66th Meeting of the SEAR Regional Committee in September 2013 in New Delhi resolved to adopt the goal of . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Tenth Annual  Measles Initiative Meeting . September 13-14, 2011 Washington, DC. Sergei Deshevoi. WHO European Region . 2. Presentation outline. Regional goal and strategy. Progress towards goal. Challenges in reaching the goal in 2015. . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. WHO Western Pacific Region. UNICEF East Asia and Pacific Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 2003. : Measles elimination to be used to strengthen routine immunization . Accelerating progress towards measles and rubella elimination. Geneva, Switzerland 21-23 June 2016 . Jenny Rota, WHO consultant. Goal is to update information to reflect current responsibilities of the network, provide best practices, resources and guidelines. Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. 2020. . Summary of the . Findings . and Implementation Status . Dr Kaushik . Banerjee. M&RI Partners' Meeting. Washington DC. 7 September 2017. 1. Objectives . of . the Review. To provide a candid review of progress . Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. easily through the air, or through contact with uids in the nose or throat. The viruses can pass from person to person by coughing, sneezing, or sharing food or drinks. Children may become inf to destroy the virus. However, as with all vaccines, 100% protection against measles, mumps and rubella cannot be guaranteed. Also itThe chance of a severe reaction from M-M-R II is very small, but ALL students are REQUIRED to provide proof of immunity to measles, mumps, and rubella (“MMR”). Before students may enroll in classes, NAU requires documentation of ONE of the following: • Tw Eliminating measles and rubella Framework for the verification process in the WHO European Region 201 4 ABSTRACT This document describes the steps to be taken to document and verify that eliminatio Accelerating Progress Towards Measles and Rubella Elimination. 23 June 2016. Geneva. , Switzerland. Minal K. Patel WHO HQ IVB/EPI. Background. Growing demand for periodic cross-sectional surveys to identify population immunity gaps.